Company / Book Value per Share
Adaptive Biotechnologies Corp Book Value per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$1.481
FY2025
5-year range
$1.397 / $4.388
FY2021-FY2025
Trend
+6.0%
vs FY2024
Sector context
#157 of 209
Health Care
What the data says
Adaptive Biotechnologies Corp's book value per share of $1.481 is lower than 75% of companies in the Health Care sector (FY2025). Book Value per Share returned to growth in FY2025 after 5 years of decline, reaching $1.481.
Based on SEC 10-K filings.
$1.481 in FY2025 with a 5-year CAGR of -24.2%.
Declined from $2.155 to $1.481 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -23.3%
- 5-Year CAGR
- -24.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 209This company $1.481 Sector average $215.686
▼
-99.3% below sector average
Key checks
Key Insights
- 5-year CAGR of -24.2%, indicating a declining trend.
- In FY2025, book value per share increased 6.0% year-over-year.
- Ranks #157 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score -1.45 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.481 | +6.0% |
| FY2024 | $1.397 | -35.2% |
| FY2023 | $2.155 | -34.4% |
| FY2022 | $3.283 | -25.2% |
| FY2021 | $4.388 | -26.1% |
| FY2020 | $5.935 | -86.7% |
| FY2019 | $44.468 | +317.6% |
| FY2018 | -$20.437 | -11.0% |
| FY2017 | -$18.416 | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026